Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sisterdot
    Junior Member
    • Apr 2013
    • 6

    DESeq2 multifactorial design

    I hope someone can help me out in defining the right design formulas and contrasts to use with DESeq2 for a (subjectively) rather complex experimental design.

    The two infection types infA and infB were considered to be equivalent by the experimental scientists.

    The experimental design was as follows:
    Code:
    	genotype	sex	inf_type	inf
    m_KO_iA	KO	m	infA	inf
    m_KO_1	KO	m	NOinf	NOinf
    m_KO_iB	KO	m	infB	inf
    m_KO_2	KO	m	NOinf	NOinf
    m_WT_iA	WT	m	infA	inf
    m_WT_1	WT	m	NOinf	NOinf
    m_WT_iB	WT	m	infB	inf
    m_WT_2	WT	m	NOinf	NOinf
    f_KO_A	KO	f	infA	inf
    f_KO_1	KO	f	NOinf	NOinf
    f_KO_iB	KO	f	infB	inf
    f_KO_2	KO	f	NOinf	NOinf
    f_WT_iA	WT	f	infA	inf
    f_WT_1	WT	f	NOinf	NOinf
    f_WT_iA	WT	f	infA	inf
    f_WT_2	WT	f	NOinf	NOinf
    And the questions i would like to pose with DESeq2 are:
    - how do the KO cells differ in their response to any treatment compared to WT cells.
    - how do the KO cells differ in their response to treatment A (infA) compared to WT cells.
    - how do the KO cells differ in their response to treatment B (infB) compared to WT cells.

    any suggestions on design formulas and contrasts to use are very much appreciated.
    i am really sorry for not providing a suggestion myself, but i am afraid that might get embarrassing

    THANKS
  • Wallysb01
    Senior Member
    • Feb 2011
    • 286

    #2
    You should read up on the interaction terms and changing the comparisons when you call the results function.

    The design probably needs to look something like:

    design ~ genotype + sex + inf_type + inf + sex:inf + sex:inf_type + genotype:inf + genotype:inf_type

    By default the results function will test the last term in your design function, so you can change that or just use the comparisons option with results.

    Comment

    • sisterdot
      Junior Member
      • Apr 2013
      • 6

      #3
      Thanks for your reply...

      i am going for
      ~ genotype + sex + inf + sex:inf + genotype:inf
      for now...

      gave a larger set of significant genes than not accounting for sex
      ~ genotype + inf + genotype:inf

      is it possible to check in advance which main effects and interactions are best to include ?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Nine Things a Sample Prep Scientist Thinks About Before Sequencing
        by SEQadmin2


        I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.


        Here are nine questions we think about, in roughly the order they matter, before...
        Yesterday, 07:11 AM
      • SEQadmin2
        From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
        by SEQadmin2


        Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


        The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
        ...
        06-02-2026, 10:05 AM
      • SEQadmin2
        Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
        by SEQadmin2


        With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


        Introduction

        Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
        05-22-2026, 06:42 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 06-17-2026, 06:09 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 06-09-2026, 11:58 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 06-05-2026, 10:09 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 06-04-2026, 08:59 AM
      0 responses
      49 views
      0 reactions
      Last Post SEQadmin2  
      Working...